Definitive Contract 75N93021C00046
Award Date
8/1/21
Potential Completion Date
7/31/22
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc., a self-certified small disadvantaged business, for the development of affinity reagents for the immune system of guinea pigs. The $300,000 firm-fixed-price contract was awarded under the SBIR program and has a completion date of June 30, 2021. Qoolabs Inc. is a corporate entity that has received over $4 million in prime...
This is a $1,500,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Qoolabs Inc., a woman-owned small disadvantaged business located in Carlsbad, California. The contract is for the production of affinity reagents for the immune system of guinea pigs, including interleukins IL1B, IL2, IL4, IL6, IL8, IL10, IL12, and IL13. There was no set-aside used for this award. Qoolabs Inc. has extensive...
This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California. The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qoolabs Inc., a self-certified small disadvantaged and woman-owned business. The $150,000 contract is for critical functions, with a period of performance ending on March 20, 2017. Qoolabs Inc. is a biotech company that has received over $4 million in prime federal contracts from the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH),...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This $600,000 definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for SBIR Topic 107 to develop affinity reagents for the immune system of the golden hamster, in alignment with the original solicitation seeking Small Business Innovation Research proposals across technical topics within NIH and CDC. Work will be performed in San Diego through September 2024 under...
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
This is a $25,374,525.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Quality Biological Inc., a minority-owned small disadvantaged business. The contract is set aside for small businesses and has an ultimate completion date of April 7, 2032. The purpose of the contract is to support the production, procurement, storage, shipping, and maintenance of high-quality...